Search research articles
Contact Us
Filters
Showing results (71-80 of 147) with videos related to
Page
of 15
Sort By:
Journal of Substance Abuse Treatment
|
November 18, 2017
Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder
An-Li Wang, Steven B Lowen, Igor Elman, et al.
Journal of Personalized Medicine
|
February 25, 2023
Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapy-A Case-Series
Anish Bajaj, David Han, Igor Elman, et al.
American Journal of Biomedical Science & Research
|
October 27, 2023
EPIC Spinal Procedure with Sound Wave Technology Induces Biomechanical Alignment Putatively Influencing Pain Response
Stan Pierce, Kenneth Blum, David Baron, et al.
Frontiers in Psychiatry
|
December 14, 2018
Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors
Kenneth Blum, Marjorie C Gondré-Lewis, David Baron, et al.
EC Psychology and Psychiatry
|
November 13, 2018
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse
Kenneth Blum, Edward J Modestino, Rajendra D Badgaiyan, et al.
International Journal of Spine Surgery
|
October 27, 2025
Prehabilitation Reimagined as Policy: A Multidimensional Framework to Reduce Pain, Opioid Use, and Surgical Risk
Kai-Uwe Lewandrowski, Morgan P Lorio, Igor Elman, et al.
Neuroscience
|
October 20, 2025
Exercise-driven modulation of glutamatergic signaling: mechanisms and clinical implications
Candice Yu, John R Tyler, Igor Elman, et al.
Schizophrenia Research
|
July 13, 2004
Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder
Vivian Mitropoulou, Marianne Goodman, Serge Sevy, et al.
Journal of Psychopharmacology (Oxford, England)
|
November 13, 2013
The effect of naltrexone on body fat mass in olanzapine-treated schizophrenic or schizoaffective patients: a randomized double-blind placebo-controlled pilot study
Tracey H Taveira, Wen-Chih Wu, Evelyne Tschibelu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 7, 2002
Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder
Daniel D Langleben, Paul D Acton, Glenn Austin, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 147) with videos related to
Sort By:
Page
of 15
Journal of Substance Abuse Treatment
|
November 18, 2017
Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder
An-Li Wang, Steven B Lowen, Igor Elman, et al.
Journal of Personalized Medicine
|
February 25, 2023
Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapy-A Case-Series
Anish Bajaj, David Han, Igor Elman, et al.
American Journal of Biomedical Science & Research
|
October 27, 2023
EPIC Spinal Procedure with Sound Wave Technology Induces Biomechanical Alignment Putatively Influencing Pain Response
Stan Pierce, Kenneth Blum, David Baron, et al.
Frontiers in Psychiatry
|
December 14, 2018
Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors
Kenneth Blum, Marjorie C Gondré-Lewis, David Baron, et al.
EC Psychology and Psychiatry
|
November 13, 2018
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse
Kenneth Blum, Edward J Modestino, Rajendra D Badgaiyan, et al.
International Journal of Spine Surgery
|
October 27, 2025
Prehabilitation Reimagined as Policy: A Multidimensional Framework to Reduce Pain, Opioid Use, and Surgical Risk
Kai-Uwe Lewandrowski, Morgan P Lorio, Igor Elman, et al.
Neuroscience
|
October 20, 2025
Exercise-driven modulation of glutamatergic signaling: mechanisms and clinical implications
Candice Yu, John R Tyler, Igor Elman, et al.
Schizophrenia Research
|
July 13, 2004
Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder
Vivian Mitropoulou, Marianne Goodman, Serge Sevy, et al.
Journal of Psychopharmacology (Oxford, England)
|
November 13, 2013
The effect of naltrexone on body fat mass in olanzapine-treated schizophrenic or schizoaffective patients: a randomized double-blind placebo-controlled pilot study
Tracey H Taveira, Wen-Chih Wu, Evelyne Tschibelu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 7, 2002
Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder
Daniel D Langleben, Paul D Acton, Glenn Austin, et al.
Page
of 15